Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Chronological

View present through 2011 View 2010 through 1991 View Alphabetical Index by Vaccine
 

Recommendations - 2016

Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons Advisory Committee on Immunization Practices (ACIP), 2016
Source: MMWR, November 4, 2016, Vol. 65(43);11891194
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 201617 Influenza Season
Source: MMWR, August 26, 2016, Vol. 65(5):1-54
HTML  |  PDF
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses—Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
Source: MMWR, March 18, 2016, Vol. 65(10):257-262
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-2
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-3
HTML  |  PDF
 

Recommendations - 2015

Back to top
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
Source: MMWR, October 23, 2015; 64(41)11711176
HTML  |  PDF
Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers
Source: MMWR, October 9, 2015; 64(39):1118-20
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 4, 2015; 64(34):944-947
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season
Source: MMWR, August 7, 2015; 64(30):818-825
HTML  |  PDF
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015
Source: MMWR, June 19, 2015; 64(23);647-650
HTML  |  PDF
Use of Serogroup B Meningococcal Vaccines in Persons Aged >10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
Source: MMWR, June 12, 2015; 64(22);608-612
HTML  |  PDF
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, March 27, 2015; 64(11):300-304
HTML  |  PDF
Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015
Source: MMWR, March 27, 2015; 64(11):305-308
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
Source: MMWR, February 6, 2015; 64(04):93-94
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
Source: MMWR, February 6, 2015; 64(04):91-92
HTML  |  PDF
 

Recommendations - 2014

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014; 63(37):822-825
HTML  |  PDF
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
Update on Recommendations for Use of Herpes Zoster Vaccine
Source: MMWR, August 22, 2014; 63(33):729-731
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
Source: MMWR, August 15, 2014; 63(327):691–697
HTML  |  PDF
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
Source: MMWR, February 7, 2014; 63(05):108–109
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
Source: MMWR, February 7, 2014; 63(5):110–112
HTML  |  PDF
 

Recommendations - 2013

Back to top
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
Source: MMWR, December 20, 2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Summary Recommendations: Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2013–14
Released: August 7, 2013
HTML  |  PDF
Updated Recommendations for Use of VariZIG -- United States, 2013
Source: MMWR, July 19, 2013; 62(28):574-6
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
Source: MMWR, May 10, 2013; 62(18):356
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 years and Adults Aged 19 Years and Older — United States, 2013
Source: MMWR Supplements, February 1, 2013; 62(01):1-21
HTML  |  PDF
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
 

Recommendations - 2012

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012; 61(40):816-9
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8
HTML  |  PDF
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
(Not an ACIP statement but an important document from CDC.)
Source: MMWR, July 6, 2012; 61(RR03):1-12
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4
HTML  |  PDF (pages 31–34)
Recommended Adult Immunization Schedule — United States, 2012
Source: MMWR, February 3, 2012; 61(4):1-7
HTML  |  PDF (pages 36–43)
 

Recommendations - 2011

Back to top
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years -- United States, 2011
Source: MMWR, February 11, 2011; 60(5):1-4
HTML  |  PDF (pages 29–32)
Recommended Adult Immunization Schedule --- United States, 2011
Source: MMWR, February 4, 2011; 60(04):1-4
HTML  |  PDF (pages 41–44)
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
This page was updated on November 5, 2016.
This page was reviewed on July 17, 2016.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.